You are currently viewing DelveInsight Business Research LLP : Global Veterinary Vaccines Market is Predicted to Cross USD 16 Billion by 2030
Representation image: This image is an artistic interpretation related to the article theme.

DelveInsight Business Research LLP : Global Veterinary Vaccines Market is Predicted to Cross USD 16 Billion by 2030

Growing demand for animal health solutions drives veterinary vaccines market growth.

The report highlights the key drivers, trends, and challenges in the market.

Market Overview

The veterinary vaccines market is expected to grow at a CAGR of 7.4% from 2022 to 2028, driven by the increasing demand for animal health solutions. The market is segmented into several key categories, including:

  • Infectious diseases: Vaccines against infectious diseases such as rabies, distemper, and parvovirus are in high demand. Non-infectious diseases: Vaccines against non-infectious diseases such as cancer and autoimmune disorders are also gaining traction. Parasitic diseases: Vaccines against parasitic diseases such as heartworms and fleas are becoming increasingly popular. ## Key Drivers**

    • Key Drivers

    Several factors are driving the growth of the veterinary vaccines market, including:

  • Rising prevalence of zoonotic diseases: The increasing prevalence of zoonotic diseases, such as COVID-19, has led to a growing demand for animal health solutions. Increasing concerns about antimicrobial resistance: The growing concern about antimicrobial resistance in animals is driving the development of new vaccines and treatments. Advances in vaccine technology: Advances in vaccine technology, such as the development of new adjuvants and delivery systems, are improving the efficacy and safety of veterinary vaccines. ## Trends**

    • Trends

    The veterinary vaccines market is experiencing several trends, including:

  • Personalized medicine: The use of personalized medicine is becoming increasingly popular in the veterinary vaccines market, with companies developing vaccines tailored to individual animal species and breeds.

    Market Overview

    The global veterinary vaccines market is projected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030, driven by increasing demand for animal health products and the growing awareness of zoonotic diseases.

    Drivers and Trends

  • Rising awareness of zoonotic diseases, such as COVID-19, SARS, and avian influenza, has led to increased demand for veterinary vaccines. The growing importance of animal health and welfare has driven the development of new vaccines and treatments. Advances in technology, such as the use of viral vectors, have improved vaccine efficacy and reduced production costs. ## Market Segmentation*

    • Market Segmentation

    The global veterinary vaccines market can be segmented into several categories, including:

  • Companion animals (dogs, cats, etc.)
  • Livestock (cattle, pigs, etc.)
  • Poultry
  • Equine

    • Regional Analysis

    North America is anticipated to dominate the global veterinary vaccines market during the forecast period, driven by the high demand for animal health products and the presence of major veterinary vaccine manufacturers. The United States is expected to account for the largest share of the North American market, driven by the high demand for companion animal vaccines. Canada is also expected to contribute significantly to the North American market, driven by the growing importance of animal health and welfare.*

    Market Challenges

    The global veterinary vaccines market faces several challenges, including:

  • Regulatory hurdles, such as the approval process for new vaccines. Competition from generic vaccines and alternative treatments.

    In 2021, the first vaccine against the African Swine Fever (ASF) was developed by the University of Cambridge and the University of Oxford.

    The Rise of Animal Vaccines

    The development of animal vaccines has been a significant milestone in the history of veterinary medicine. In recent years, the industry has witnessed a surge in the production and distribution of vaccines against various diseases affecting animals. This trend is expected to continue, driven by the growing demand for animal health products and the increasing awareness of the importance of animal welfare.

    Key Developments in Animal Vaccines

  • Fencovis: Launched in September 2022, Fencovis is the first vaccine against calf disease. This vaccine has the potential to revolutionize the dairy industry by reducing the incidence of calf diseases, which can have significant economic and welfare implications for farmers. Anocovax: Launched in June 2022, Anocovax is India’s first homegrown COVID-19 vaccine for animals. Produced by the ICAR-National Research Centre on Equines (NRCE), this vaccine has the potential to improve animal health and reduce the economic burden of COVID-19 on the agricultural sector.

    Here’s how biotechnology is revolutionizing the veterinary vaccine industry.

    The Rise of Biotechnology in Veterinary Vaccines

    The use of biotechnology in veterinary vaccines has been on the rise over the past few decades. This is largely due to the increasing demand for more effective and safer vaccines that can protect animals from various diseases. Biotechnology has enabled the development of vaccines that are more potent, longer-lasting, and easier to administer.

    Key Benefits of Biotechnology in Veterinary Vaccines

  • Improved efficacy: Biotechnology has enabled the development of vaccines that are more effective in preventing diseases. For example, the use of recombinant DNA technology has led to the development of vaccines that can protect against diseases such as rabies and distemper.

    The Rise of Veterinary Vaccines in North America

    The North American region is poised to lead the global veterinary vaccines market, driven by a combination of factors. A well-established veterinary healthcare system, coupled with the presence of prominent vaccine manufacturers, has created a favorable environment for the growth of this market.

    Key Drivers of the Market

  • Established Veterinary Healthcare System: North America has a robust veterinary healthcare system, which provides a steady demand for veterinary vaccines. The region’s veterinarians and pet owners are well-informed about the importance of vaccination and are willing to invest in their pets’ health. Presence of Leading Vaccine Manufacturers: The presence of leading vaccine manufacturers, such as Zoetis and Merck Animal Health, has contributed significantly to the growth of the market. These companies invest heavily in research and development, ensuring the availability of effective vaccines. Continuous Innovation: The presence of leading vaccine manufacturers in North America has fostered continuous innovation in the field of veterinary vaccines. This has led to the development of new vaccines and the improvement of existing ones, further driving the market’s growth. ## The Impact of the Market on Pet Owners**

    • The Impact of the Market on Pet Owners

    The growth of the veterinary vaccines market in North America has a significant impact on pet owners.

    The region is also expected to see significant growth in the veterinary vaccines market due to the increasing awareness of animal health and the growing demand for vaccines against emerging diseases.

    Market Overview

    The North American veterinary vaccines market is expected to continue its dominance in the global market, driven by the increasing demand for vaccines against emerging diseases and the growing awareness of animal health.

    This article will delve into the current state of the veterinary vaccines market, highlighting key trends, drivers, and challenges.

    Market Overview

    The veterinary vaccines market is a rapidly growing industry, driven by increasing awareness of animal health and welfare. The market size is projected to reach $13.4 billion by 2025, growing at a compound annual growth rate (CAGR) of 7.5% from 2020 to 2025. This growth is attributed to the rising demand for vaccines in companion animals, livestock, and veterinary clinics.

    Key Trends

  • Increasing awareness of animal health and welfare: The growing concern for animal welfare and the importance of preventive healthcare has led to an increase in demand for veterinary vaccines. Advancements in vaccine technology: The development of new vaccine technologies, such as recombinant vaccines and mRNA vaccines, has improved the efficacy and safety of veterinary vaccines. Rise of companion animal vaccines: The demand for vaccines in companion animals, such as dogs and cats, has increased significantly, driven by the growing pet humanization trend. ## Drivers of the Market**

    • Drivers of the Market

    The veterinary vaccines market is driven by several factors, including:

  • Zoonotic disease prevention: The risk of zoonotic diseases, such as rabies and avian influenza, has increased, leading to a greater need for effective vaccines. Food safety: The importance of food safety has led to an increase in demand for vaccines that prevent diseases in livestock, such as foot-and-mouth disease and swine fever.

    The Rise of Zoonotic Diseases

    The increasing prevalence of zoonotic diseases has become a pressing concern in recent years. These diseases, which can be transmitted from animals to humans, pose a significant threat to global health.

    The companion animal segment is expected to grow at a CAGR of 7.5% from 2023 to 2028, while the livestock segment is projected to grow at a CAGR of 4.5% during the same period.

    The Companion Animal Segment: A Growing Market

    The companion animal segment is experiencing significant growth, driven by the increasing number of pet owners who consider their pets as part of the family. This trend is reflected in the rising pet population, with an estimated 1.5 billion pets worldwide.

    Growing demand for animal health products drives the veterinary vaccines market forward.

    The global veterinary vaccines market is expected to grow at a CAGR of ~9% from 2023 to 2030, reaching a market size of USD 16 billion by 2030.

    Types of Vaccines

    The vaccines market can be segmented into various types, each with its unique characteristics and applications. Understanding these differences is crucial for developing effective vaccination strategies.

    Inactivated Veterinary Vaccines

    Inactivated veterinary vaccines are made from killed or inactivated pathogens. These vaccines are often used for diseases that are not typically fatal in healthy animals, such as rabies and distemper. They are also used for diseases that are not easily transmissible between animals, such as parvovirus. Advantages: + Easy to produce and distribute + Can be stored at room temperature + Can be used in combination with other vaccines

  • Disadvantages:

    • + May not provide long-term immunity + May not be effective against highly contagious diseases

    Live-Attenuated Veterinary Vaccines

    Live-attenuated veterinary vaccines contain weakened or attenuated pathogens. These vaccines are often used for diseases that are highly contagious, such as distemper and parvovirus. They are also used for diseases that are typically fatal in healthy animals, such as rabies. Advantages: + Provide long-term immunity + Can be used to boost immunity in animals that have previously been vaccinated + Can be used to develop vaccines against new diseases

  • Disadvantages:

    • + May cause adverse reactions in some animals + May not be effective against diseases that are not highly contagious

    Subunit Veterinary Vaccines

    Subunit veterinary vaccines contain only specific components of a pathogen, such as proteins or sugars.

    Hepatitis B vaccine market poised for significant growth driven by increasing awareness and vaccination efforts worldwide.

    The report provides a comprehensive overview of the Hepatitis B vaccine market, including its current and forecasted epidemiology, market trends, and market drivers.

    Hepatitis B Vaccine Market Overview

    The Hepatitis B vaccine market is a rapidly growing industry, driven by increasing awareness and vaccination efforts worldwide. The report provides a comprehensive overview of the market, including its current and forecasted epidemiology, market trends, and market drivers.

    Current Epidemiology

    The Hepatitis B virus (HBV) is a major public health concern, with an estimated 257 million people worldwide infected with the virus. The majority of these cases are found in Asia and Africa, where access to healthcare and vaccination programs is limited. The global HBV prevalence is estimated to be 3.9% of the total population. The majority of HBV cases are acute, with approximately 1.4 million new cases reported annually. Chronic HBV infection is a major cause of liver cancer, cirrhosis, and liver failure.

    Market Trends

    The Hepatitis B vaccine market is expected to grow significantly over the next decade, driven by increasing awareness and vaccination efforts worldwide. The global Hepatitis B vaccine market is expected to reach $10.3 billion by 2025, growing at a CAGR of 7.5% from 2020 to 2025. The market is expected to be driven by increasing demand for vaccines in emerging markets, particularly in Asia and Africa.

    Market Overview

    The veterinary diagnostic imaging market is a rapidly growing industry, driven by advances in technology and an increasing demand for high-quality diagnostic imaging solutions. The market is expected to continue growing at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2028, driven by factors such as:

  • Increasing prevalence of diseases in companion animals
  • Growing demand for high-quality diagnostic imaging solutions
  • Advancements in technology, including the development of new imaging modalities and improved image processing algorithms

    • Key Drivers

  • Increasing prevalence of diseases in companion animals: The prevalence of diseases in companion animals, such as cancer and cardiovascular disease, is increasing, leading to a growing demand for diagnostic imaging solutions. Growing demand for high-quality diagnostic imaging solutions: Pet owners are increasingly seeking high-quality diagnostic imaging solutions to ensure the best possible care for their pets.

    are some of the key players in the animal nutrition market.

    Animal Nutrition Market Overview

    The animal nutrition market is a rapidly growing industry, driven by increasing demand for animal feed and nutritional supplements. The market is expected to reach $83.4 billion by 2030, growing at a CAGR of 4.5% from 2022 to 2030.

    Market Drivers

    Several factors are driving the growth of the animal nutrition market. These include:

  • Increasing global population and demand for animal protein
  • Growing awareness of animal health and welfare
  • Advances in animal nutrition technology and research
  • Increasing demand for sustainable and environmentally friendly animal feed

    • Market Barriers

    Despite the growth prospects, the animal nutrition market faces several challenges and barriers.

  • The phrase “empower pharma companies” is rephrased to “empower their overall performance” to make the language more concise and focused. ## The Role of DelveInsight in the Pharmaceutical Industry

    • The Role of DelveInsight in the Pharmaceutical Industry

    DelveInsight is a renowned life sciences consulting and market research firm that specializes in serving the pharmaceutical industry. By offering tailored solutions, they empower their overall performance.

    Expertise and Services

    DelveInsight’s expertise lies in providing comprehensive market research and consulting services to pharmaceutical companies.

    Leave a Reply